FDA11月份批准的药物
公司 | 药品 | 适应症 |
健赞(赛诺菲子公司,马萨诸塞州剑桥) | Lemtrade | 多发性硬化症复发 |
基因泰克(南加州) | Avastin | 铂类耐药的复发性卵巢癌 |
远藤国际集团(都柏林) | Valcyte仿制药 | 巨细胞病毒感染 |
Medivir AB公司(胡丁厄,瑞典) | Olysio | 丙肝基因I型 |
赛诺菲巴斯德 | Fluzone | 流感 |
Veloxis制药(丹麦霍斯霍尔姆) | Envarsus | 肾脏移植 |
FDA approvals in November
Company | Drug | Indication |
Genzyme (a Sanofi company; Cambridge, Mass.) | Lemtrade | Relapsing forms of multiple sclerosis |
Genentech Inc. (South San Francisco) | Avastin | Platinum-resistant, recurrent ovarian cancer |
Endo International plc(Dublin) | Generic Valcyte | Cytomegalovirus |
Medivir AB (Huddinge, Sweden) | Olysio | Genotype 1 hepatitis C virus |
Sanofi Pasteur (Stillwater, Pa.; division of Sanofi SA) | Fluzone | Influenza |
Veloxis Pharmaceuticals A/S (Horsholm, Denmark) | Envarsus XR | Kidney transplant |
欢迎光临 药群论坛 (http://www.yaoqun.net/) | Powered by Discuz! X3.2 |